Chronic performance of polyurethane catheters covalently coated with ATH complex: A rabbit jugular vein model

Biomaterials

Volumn 27, Issue 29, 2006, Pages 5107-5117

  Klement, Petr ^a   Du, Ying Jun ^a   Berry, Leslie R ^a   Tressel, Paul ^a   Chan, Anthony K C ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Anticoagulant; Antithrombin; Heparin; Polyurethane; Surface grafting

Indexed keywords

ANTICOAGULANT; ANTITHROMBIN; HEPARIN; JUGULAR VEIN; SURFACE GRAFTING;

ATOMIC FORCE MICROSCOPY; COAGULATION; COMPLEXATION; POLYURETHANES; SCANNING ELECTRON MICROSCOPY;

CATHETERS;

ANTICOAGULANT AGENT; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A INHIBITOR; FIBRIN; HEPARIN; POLYURETHAN; PROTEIN; PROTEINASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; ATOMIC FORCE MICROSCOPY; BLOOD SAMPLING; CATHETER THROMBOSIS; CELL ADHESION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; DRUG COATING; DRUG SCREENING; ISOTOPE LABELING; JUGULAR VEIN; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCANNING ELECTRON MICROSCOPY; STATISTICAL SIGNIFICANCE; VASCULAR PATENCY; VEIN OCCLUSION;

ANIMALS; ANTITHROMBINS; CATHETERS, INDWELLING; COATED MATERIALS, BIOCOMPATIBLE; HEPARIN; HUMANS; JUGULAR VEINS; MALE; MODELS, ANIMAL; POLYURETHANES; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 33745231635     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2006.05.005     Document Type: Article

References (37)

1. Ikada Y. Application of radiation to biomedical materials and artificial organs. Radioisotopes 33 (1984) 397-406
2. Brash J.L. Exploiting the current paradigm of blood-material interactions for the rational design of blood-compatible materials. J Biomater Sci Polym Ed 11 (2000) 1135-1146
3. Tanzi M.C. Bioactive technologies for hemocompatibility. Expert Rev Med Dev 2 (2005) 473-492
4. Damus P.S., Hicks M., and Rosenberg R.D. Anticoagulant action of heparin. Nature 246 (1973) 355-357
5. Bernacca G.M., Gulbransen M.J., Wilkinson R., and Wheatley D.J. In vitro blood compatibility of surface-modified polyurethanes. Biomaterials 19 (1998) 1151-1165
6. Park K.D., Okano T., Nojiri C., and Kim S.W. Heparin immobilization onto segmented polyurethane-urea surfaces-effect of hydrophilic spacers. J Biomed Mater Res 22 (1988) 977-992
7. Hoar P.F., Wilson R.M., Mangano D.T., Avery G.J., Szarnicki R.J., and Hill J.D. Heparin bonding reduces thrombogenicity of pulmonary-artery catheters. N Engl J Med 305 (1981) 993-995
8. Mangano D.T. Heparin bonding and long-term protection against thrombogenesis. N Engl J Med 307 (1982) 894-895
9. Randolph A.G., Cook D.J., Gonzales C.A., and Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 113 (1998) 165-171
10. Krafte-Jacobs B., Sivit C.J., Mejia R., and Pollack M.M. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr 126 (1995) 50-54
11. Conn G., Kidane A.G., Punshon G., Kannan R.Y., Hamilton G., and Seifalian A.M. Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?. Expert Rev Med Dev 3 (2006) 245-261
12. Lau K.W., Hung J.S., and Sigwart U. The current status of stent placement in small coronary arteries <3.0 mm in diameter. J Invasive Cardiol 16 (2004) 411-416
13. Nelson S.R., deSouza N.M., and Allison D.J. Endovascular stents and stent-grafts: is heparin coating desirable?. Cardiovasc Intervent Radiol 23 (2000) 252-255
14. Chan A., Berry L., O'Brodovich H., Klement P., Mitchell L., Baranowski B., et al. Covalent antithrombin-heparin complexes with high anticoagulant activity. Intravenous, subcutaneous, and intratracheal administration. J Biol Chem 272 (1997) 22111-22117
15. Berry L., Stafford A., Fredenburgh J., O'Brodovich H., Mitchell L., Weitz J., et al. Investigation of the anticoagulant mechanisms of a covalent antithrombin-heparin complex. J Biol Chem 273 (1998) 34730-34736
16. Olson S.T., Bjork I., Sheffer R., Craig P.A., Shore J.D., and Choay J. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 267 (1992) 12528-12538
17. Polderman K.H., and Girbes A.J. Central venous catheter use. Part 1: mechanical complications. Intensive Care Med 28 (2002) 1-17
18. Uyama Y., Tadokoro H., and Ikada Y. Low-frictional catheter materials by photo-induced graft polymerization. Biomaterials 12 (1991) 71-75
19. Du Y.J., Klement P., Berry L.R., Tressel P., and Chan A.K. In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex. Thromb Haemost 94 (2005) 366-372
20. Mermel L.A. Prevention of intravascular catheter-related infections. Ann Intern Med 132 (2000) 391-402
21. Hatton M.W., Berry L.R., Machovich R., and Regoeczi E. Tritiation of commercial heparins by reaction with NaB3H4: chemical analysis and biological properties of the product. Anal Biochem 106 (1980) 417-426
22. Grasel T., and Cooper S. Surface properties and blood compatibility of polyurethaneureas. Biomaterials 7 (1986) 315-328
23. Solomon DD, McGary CW, Pascarella VJ. Permanently bonded antithrombogenic polyurethane surface. US patent no. 4,642,242, 1987.
24. Scholander E. Process for preparing surface modification substances. US patent no. 6,461,665, 2002.
25. Klement P., Du Y.J., Berry L., Andrew M., and Chan A.K. Blood-compatible biomaterials by surface coating with a novel antithrombin-heparin covalent complex. Biomaterials 23 (2002) 527-535
26. Woodhouse K.A., Klement P., Chen V., Gorbet M.B., Keeley F.W., Stahl R., et al. Investigation of recombinant human elastin polypeptides as non-thrombogenic coatings. Biomaterials 25 (2004) 4543-4553
27. Karrer L., Duwe J., Zisch A.H., Khabiri E., Cikirikcioglu M., Napoli A., et al. PPS-PEG surface coating to reduce thrombogenicity of small diameter ePTFE vascular grafts. Int J Artif Organs 28 (2005) 993-1002
28. Groll J., Ademovic Z., Ameringer T., Klee D., and Moeller M. Comparison of coatings from reactive star shaped PEG-stat-PPG prepolymers and grafted linear PEG for biological and medical applications. Biomacromolecules 6 (2005) 956-962
29. Chandy T., Rao G.H., Wilson R.F., and Das G.S. Delivery of LMW heparin via surface coated chitosan/peg-alginate microspheres prevents thrombosis. Drug Deliv 9 (2002) 87-96
30. Spijker H.T., Graaff R., Boonstra P.W., Busscher H.J., and van Oeveren W. On the influence of flow conditions and wettability on blood-material interactions. Biomaterials 24 (2003) 4717-4727
31. Lee K.H., Han J.K., Byun Y., Moon H.T., Yoon C.J., Kim S.J., et al. Heparin-coated angiographic catheters: an in vivo comparison of three coating methods with different heparin release profiles. Cardiovasc Intervent Radiol 27 (2004) 507-511
32. Tepe G., Schmehl J., Wendel H.P., Schaffner S., Heller S., Gianotti M., et al. Reduced thrombogenicity of nitinol stents-in vitro evaluation of different surface modifications and coatings. Biomaterials 27 (2006) 643-650
33. Wang A., Cao T., Tang H., Liang X., Salley S.O., and Ng K.Y.S. In vitro haemocompatibility and stability of two types of heparin-immobilized silicon surfaces. Colloids Surf B Biointerfaces 43 (2005) 245-255
34. Michanetzis G.P.A., Katsala N., and Missirlis Y.F. Comparison of haemocompatibility improvement of four polmeric biomaterials by two heparinization techniques. Biomaterials 24 (2003) 677-688
35. Da Luz Moreira P., Wada M.L., and Novello W.P. Importance of uniform heparin coating on biopolymers. Artif Organs 24 (2000) 209-211
36. Chan A.K.C., Berry L.R., Monagle P.T., and Andrew M. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential. Thromb Haemost 87 (2002) 606-613
37. Chan A.K., Du Y.J., Berry L.R., Tressel P., Vlasin M., Benetka M., et al. Evaluation of covalent antithrombin-heparin complex coated polyurethane central venous catheters in acute and chronic rabbit models. Trans Soc Biomater 25 (2002) 149